Literature DB >> 23509544

HbA1c testing in the community pharmacy: A new strategy to improve care for patients with diabetes.

John Papastergiou, Amy Rajan, Artemis Diamantouros, John Zervas, Justin Chow, Peter Tolios.   

Abstract

Entities:  

Year:  2012        PMID： 23509544      PMCID： PMC3567797          DOI： 10.3821/145.4.cpj165

Source DB:  PubMed          Journal:  Can Pharm J (Ott)        ISSN： 1715-1635


× No keyword cloud information.
  6 in total

1.  Standards of medical care in diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2005-01       Impact factor: 19.112

2.  Analytic bias among certified methods for the measurement of hemoglobin A1c: a cause for concern?

Authors:  Earle W Holmes; Cağatay Erşahin; Geri J Augustine; Gerald A Charnogursky; Margie Gryzbac; Joanne V Murrell; Kathleen M McKenna; Fadi Nabhan; Stephen E Kahn
Journal:  Am J Clin Pathol       Date:  2008-04       Impact factor: 2.493

3.  Glycemic control in community-dwelling patients with type 2 diabetes.

Authors:  Yazid N Al Hamarneh; Meagen Rosenthal; Ross T Tsuyuki
Journal:  Can Pharm J (Ott)       Date:  2012-03

4.  A diabetes report card for the United States: quality of care in the 1990s.

Authors:  Jinan B Saaddine; Michael M Engelgau; Gloria L Beckles; Edward W Gregg; Theodore J Thompson; K M Venkat Narayan
Journal:  Ann Intern Med       Date:  2002-04-16       Impact factor: 25.391

5.  Glycemic control and morbidity in the Canadian primary care setting (results of the diabetes in Canada evaluation study).

Authors:  Stewart B Harris; Jean-Marie Ekoé; Yola Zdanowicz; Susan Webster-Bogaert
Journal:  Diabetes Res Clin Pract       Date:  2005-10       Impact factor: 5.602

6.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321
  6 in total
  8 in total

1.  Quality Control of Norwegian Pharmacy HbA1c Testing: A Modest Beginning.

Authors:  Una Ørvim Sølvik; Aslaug Johanne Risøy; Reidun L S Kjome; Sverre Sandberg
Journal:  J Diabetes Sci Technol       Date:  2018-04-05

2.  Point-of-Care HbA1c Testing with the A1cNow Test Kit in General Practice Dental Clinics: A Pilot Study Involving Its Accuracy and Practical Issues in Its Use.

Authors:  Shiela M Strauss; Mary Rosedale; Michael A Pesce; Caroline Juterbock; Navjot Kaur; Joe DePaola; Deborah Goetz; Mark S Wolff; Dolores Malaspina; Ann Danoff
Journal:  Point Care       Date:  2014-12

3.  Integrating Rapid Diabetes Screening Into a Latinx Focused Community-Based Low-Barrier COVID-19 Testing Program.

Authors:  Andrew D Kerkhoff; Susana Rojas; Douglas Black; Salustiano Ribeiro; Susy Rojas; Rebecca Valencia; Jonathan Lemus; Joselin Payan; John Schrom; Diane Jones; Simone Manganelli; Shalom Bandi; Gabriel Chamie; Valerie Tulier-Laiwa; Maya Petersen; Diane Havlir; Carina Marquez
Journal:  JAMA Netw Open       Date:  2022-05-02

4.  Diabetic Profile- Screening of HBA1C - A Random Community Assessment.

Authors:  M R Suchitra; K Jaiganesh; S Parthasarathy
Journal:  J Clin Diagn Res       Date:  2013-10-05

5.  Community Pharmacy-Based eGFR Screening for Early Detection of CKD in High Risk Patients.

Authors:  John Papastergiou; Michelle Donnelly; Wilson Li; Robert D Sindelar; Bart van den Bemt
Journal:  Can J Kidney Health Dis       Date:  2020-05-18

6.  Beliefs About Medicine and Glycemic Control Among Type 2 Diabetes Patients: A Cross-Sectional Study in West Bank, Palestine.

Authors:  Maher R Khdour; Heba B Awadallah; Mustafa A Alnadi; Doaa H Al-Hamed
Journal:  J Prim Care Community Health       Date:  2020 Jan-Dec

7.  Community pharmacy-based H. pylori screening for patients with uninvestigated dyspepsia.

Authors:  John Papastergiou; Michelle Donnelly; Terence Yuen; Wilson Li; Bart van den Bemt
Journal:  Can Pharm J (Ott)       Date:  2020-02-18

8.  Risk assessment and HbA1c measurement in Norwegian community pharmacies to identify people with undiagnosed type 2 diabetes - A feasibility study.

Authors:  Aslaug Johanne Risøy; Reidun Lisbet Skeide Kjome; Sverre Sandberg; Una Ørvim Sølvik
Journal:  PLoS One       Date:  2018-02-23       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.